Nuveen
OM icon

Nuveen’s Outset Medical OM Stock Holding History

Nuveen’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-65,585
Closed -$252K – 3822
2026
Q1 		$252K Buy
65,585
+281
+0.4% +$1.15K ﹤0.01% 3043
2025
Q4 		$242K Buy
65,304
+30,628
+88% +$263K ﹤0.01% 3100
2025
Q3 		$490K Sell
34,676
-4,941
-12% -$77K ﹤0.01% 2901
2025
Q2 		$761K Buy
+39,617
New +$618K ﹤0.01% 2723
2024
Q2 		– Sell
-10,352
Closed -$345K – 3391
2024
Q1 		$345K Buy
10,352
+1,742
+20% +$88.2K ﹤0.01% 3070
2023
Q4 		$699K Sell
8,610
-12,734
-60% -$1.04M ﹤0.01% 2888
2023
Q3 		$3.48M Sell
21,344
-513
-2% -$121K ﹤0.01% 2045
2023
Q2 		$7.17M Buy
21,857
+670
+3% +$204K ﹤0.01% 1708
2023
Q1 		$5.85M Sell
21,187
-3,084
-13% -$1.13M ﹤0.01% 1801
2022
Q4 		$9.4M Buy
24,271
+15,283
+170% +$4.31M ﹤0.01% 1537
2022
Q3 		$2.15M Sell
8,988
-95
-1% -$25.4K ﹤0.01% 2366
2022
Q2 		$2.02M Buy
9,083
+119
+1% +$51.2K ﹤0.01% 2431
2022
Q1 		$5.73M Sell
8,964
-1,031
-10% -$620K ﹤0.01% 1987
2021
Q4 		$6.51M Sell
9,995
-877
-8% -$649K ﹤0.01% 1953
2021
Q3 		$8.97M Sell
10,872
-10,411
-49% -$7.09M ﹤0.01% 1857
2021
Q2 		$16M Buy
21,283
+18,022
+553% +$13.8M ﹤0.01% 1542
2021
Q1 		$2.66M Buy
3,261
+836
+34% +$645K ﹤0.01% 2478
2020
Q4 		$2.07M Buy
+2,425
New +$1.87M ﹤0.01% 2497

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nuveen's OM Position: Q2 2026 in Review

Nuveen sold out of Outset Medical (OM) in Q2 2026, closing a stake of 65,585 shares — an estimated $252K sold.

Nuveen first reported a position in OM in Q4 2020 and held it in 18 quarters. The position peaked at $16M in Q2 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Nuveen reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 65,585 Outset Medical shares in Q2 2026, an estimated $252K.
  • Nuveen first reported a position in Outset Medical in Q4 2020 and held it in 18 quarters.
  • Nuveen's Outset Medical position peaked at $16M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.